COMMUNIQUÉS West-GlobeNewswire
-
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
16/04/2026 -
Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway
16/04/2026 -
Medera Receives FDA Fast Track Designation for Gene Therapy Targeting Duchenne Muscular Dystrophy-Associated Cardiomyopathy
16/04/2026 -
Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
16/04/2026 -
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
16/04/2026 -
Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer
16/04/2026 -
Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026
16/04/2026 -
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function
16/04/2026 -
MIMEDX Announces Restructuring and Cost Reduction Initiative
16/04/2026 -
Blood Cancer Patients and Their Supporters Cycle Across Iceland to Raise Funds and Awareness for Multiple Myeloma and the International Myeloma Foundation’s Research
16/04/2026 -
Harrow Announces the Issuance of J-Code for IOPIDINE® 1%
16/04/2026 -
Wellcome Leap Announces $2 Million Prize in $50 Million Quantum for Bio Challenge Program
16/04/2026 -
Nanox.ARC X Digital Advanced 3D imaging built for access and powered by innovation Wins 2026 Red Dot Award for Product Design
16/04/2026 -
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
16/04/2026 -
Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications
16/04/2026 -
Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026
16/04/2026 -
Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors
16/04/2026 -
VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval
16/04/2026 -
Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors
16/04/2026
Pages